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Abstract Objective To study the efficacy and safety of the Jiang Tang Fang Long Jiao Nang (Hypoglycemic
Anti-Deafness Capsule) in treating non-insulin dependent diabetes mellitus with hearing loss. Methods
Two hundred ninety six patients with non-insulin dependent diabetes mellitus and hearing loss were ran⁃
domly assigned to a treatment group（n=164, 208 ears）and a control group（n=132, 184 ears）. Patients in
the treatment group were treated with the Jiang Tang Fang Long Jiao Nang and supplement herbal prepa⁃
rations as indicated by traditional Chinese medicine dialectical assessment, while control patients re⁃
ceived glibenclamide and conventional treatments for deafness. Hearing, fasting blood glucose（FBG）,
post-prandial blood glucose（PBG）, 24 hour urine sugar, platelet function indices, blood superoxide dis⁃
mutase（SOD）and lipid peroxides（LPO）levels, and symptom improvement were compared between the
two groups. Results The rate of hearing improvement was 56.7% for the treatment group and 26.6% for the
control. FBG, PBG and 24 hour urine sugar improved in both groups, but the last two were superior in the
treatment group compared to the control. Symptoms improvement was also superior in the treatment
group compared to the control. In patients receiving Jiang Tang Fang Long Jiao Nang treatment, platelet
function indices, SOD and LPO were all improved, while only LOP improvement was noticed in control
patients. No acute or long-term toxicity was demonstrated for the Jiang Tang Fang Long Jiao Nang in ani⁃
mal tests. The Jiang Tang Fang Long Jiao Nang lowered blood glucose and serum triglycerides in a rat
model of alloxan-induced diabetes. Conclusion The Jiang Tang Fang Long Jiao Nang is effective in im⁃
proving hearing and diabetic indices in diabetic patients with deafness, without significant side effects.
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Introduction
Treatment of sensorineural deafness associated
with diabetes is difficult due to the lack of under⁃
standing of its mechanisms. In previous papers1-2,
the authors have reported treating hearing loss in
diabetic patients using the Jiang Tang Fang Long
Jiao Nang（Hypoglycemic Anti-Deafness Capsule）.
This paper summarizes some of the preliminary re⁃
sults of clinical and animal studies on this herbal
paration.
Clinical Trials
Original Article
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1 Materials and Methods
1.1 Subjects: Two hundred ninety six cases（392
ears）of non-insulin dependent diabetes mellitus
（NIDDM）with deafness were identified. Hearing
loss in these cases was characterized as mild（n =
68）, moderate（n = 112）, moderately severe（n =
128）, severe（n = 56）and profound（n = 28）using
the ISO Standard 1964. Hearing loss was unilateral
in 216 and bilateral in 156 cases. The onset was
sudden in 44 and gradual in 348 cases. The
patients were randomly assigned to a treatment
（n = 164, 208 ears）and a control group（n = 132,
184 ears）. There were 68 males and 96 females in
the treatment group, and 64 males and 68 females
in the control group. The average age was 51.7
（ranging from 36 to 71） years for the treatment
group and 51.1(34 to 70) years for the control
group. The average duration of hearing loss was 4.7
(ranging from 1 to 11) years for the treatment
group and 4.4(1 to 10）years for the control group.
Patients with histories of traumatic brain injury,
toxic diseases, noise induced deafness, poisoning,
etc., were not included in this study.
1.2 Diagnostic Criteria: The diagnosis of NIDDM
was made in line with the World Health
Organization standards. Traditional Chinese
medicine（TCM）dialectical types were determined
in accordance with the New Chinese Medicine
Clinical Research Guiding Principles 3.
1.3 Audiometric tests and platelet function as⁃
says: Hearing was tested using a Madsen OB 802
pure-tone audiometer and a Madsen ZO 72 MB
acoustic impedance audiometer(Madsen Electron⁃
ics, Denmark). Platelet adhesion was tested using
the turbidimetric method and platelet aggregation
using a TYXN-90 coagulometer(Tongyong Tech⁃
nology Institute, Shanghai, China).
1.4 Blood superoxide dismutase(SOD) activity
and lipid peroxides(LPO) tests: Centrifugal serum
of fasting blood from the upper limb was taken
and SOD activity and LPO content were
determined using the xanthopterin enzymatic
oxidation method and the thiobarbituric acid
assay, respectively.
1.5 Blood and urine glucose tests: Fasting blood
glucose（FBG） and 2 hour postprandial blood
glucose（PBG）were determined using the glucose
oxidase method. Total 24 hour urine sugar was
measured. Blood and urine sugar were tested
before and at two weeks after the initiation of
treatment.
2 Treatment
2.1 The treatment group：The Jiang Tang Fang
Long Jiao Nang was administered orally at 5 caps,
t. i.d. The Jiang Tang Fang Long Jiao Nang was
formulated using the following herbal
components: kudzu vine root（30 g）, salvia root
（30 g）, ligusticum wallichii（30 g）, rehmannia
glutinosa（20 g）, Anhui yam（20 g）, poris cocos
（30 g）, peony root bark （10 g）, alisma
plantago-aquitica var. orientale(20 g), Shuanzhuyu
and magnet （50 g）. Each dispensed capsule
weighed 0.5 g.
Supplement Capsules No. 1, 2 and 3 were added
when indicated by TCM dialectic assessment.
Capsule 1 contained gypsum（30 g）, anemarrhena
asphodeloides(15 g), coptis chinensis（10 g） and
Zhejiang figwort root（20 g）, and was added when
“Dry Heat from Yin Deficiency”was identified.
Treatment was supplemented with Capsule 2,
containing astragalus membranaceus （30g）,
adenophora stricta（20 g）, ophionogon japonicus
（20 g） and tricosanthes kirilowii（30 g）, when
there was“Deficiency of Qi and Yin”, and with
Capsule 3, which contained epimedium
macranithum （10 g）, prepared common
monkshood daughter root（10 g）, Chinese cassia
（5 g）, lycium chinense(15 g) and morinda root（10
g）, when“Deficiency of both Yin and Yang”was
present. Each supplement capsule weighed 0.5 g
and was administered orally at 3 to 5 caps, t. i. d.
2.2 The control group：Glibenclamide was given
orally 0.5 hour after meals, doses adjusted for
optimal glucose control. This was supplemented
with anisodamine（10 mg, b. i. d.）, Vit. B1（20 mg,
t. i. d） and Fu Fang Dan Shen（a salvia root
preparation, 3 tabs, t. i. d）. Treatment results were
assessed after 48 days.
2.3 Statistics: Treatment results were analyzed
using the SPSS 11.0 software. Means and standard
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Group
Treatment
Control
Total
208
184
Excellent
37
0
Good
53
16
Fair
28
33
No Effect
90
135
Combined Effective rate (%)
56.7
26.6
Table 1 Comparison of hearing improvement
Table 2 Comparison of FBG, PBG and 24 hour Urine Sugar（mean ± SD）
Group
Treatment
Control
Before
After
Before
After
No. Of Case
164
132
FBG（mm01/L）
11.90±3.53
7.51±2.22*
11.50±3.81
8.54±3.81
PBG（mm01/L）
15.90±2.95
8.18±2.12**#
15.71±4.40
9.50±2.10*
Urine sugar（g/24h）
15.15±7.03
3.60±3.48**#
16.17±7.07
6.80±4.80*
*P＜0.05, **P＜0.01, compared to pretreatment levels. #P＜0.05, compared to the control.
deviations were calculated. Inter-group differenc⁃
es were examined using student t test.
3 Results
3.1 Audiometric changes: Based upon the crite⁃
ria reported by the Division of Hearing, Beijing In⁃
stitute of Otolaryngology4, post-treatment audio⁃
metric results were rated in four categories. Excel⁃
lent: improvement in both subjective hearing and
tinnitus ratings. Thresholds at all test frequencies
were within normal range. Good: Thresholds im⁃
proved by 30 dB or more compared to pre-treat⁃
ment levels or to a useful level with self-reposted
improvement. Fair: Threshold improvement was
between 15 and 30 dB with self-reposted im⁃
proved. No effect: Improvement at most frequen⁃
cies was less than 15 dB.
3.2 Comparison between the two groups: Using
the criteria listed above, hearing improvement rate
was at 56.7% for the treatment group, compared to
26.6% for the control group（Table 1）.
3.3 Glucose control: All three indices improved
in both groups（P < 0.05）. Greater improvement
was seen in patients in the treatment group for
PBG and 24 hour urine sugar compared to those in
the control group （P< 0.05）, while FBG
improvement was similar between the two groups
（P< 0.05）（Table 2）.
3.4 Improvement of symptoms: More patients in
the treatment group reported various extents of im⁃
provement of diabetic symptoms（e.g., polydipsia,
polyuria, hunger, weight loss and weakness）than
those in the control group（Table 3）.
3.5 Platelet function indices, SOD and LPO: In
the treatment group, platelet adhesion rate, plate⁃
let aggregation rate and LPO level were reduced af⁃
ter treatment（P < 0.05）, while SOD activity in⁃
creased（P <0.05）. In the control group, LPO level
was decreased（P< 0.05）while the rest three indi⁃
ces remained unchanged（P<0.05）（Table 4）.
Animal Studies
1 Materials
Treatment agents: The Jiang Tang Fang Long Jiao
Nang was developed by the authors.
Tetraoxypyrimidine（BDH Chemicals Ltd., Poole,
England） was prepared as 5% solution for
subcutaneous injection.
Animals: Animals used in the study included
Kunming mice（18-22 g bath sexes）, young Wistar
rats（80-120 g, both sexes）and adult Wistar rats
（200-220 g, both sexes）.
2 Methods and Results
2.1 Acute Toxicity Test: The LD50 was not reached
at the maximum Jiang Tang Fang Long Jiao Nang
dose used in Kunming mice, The maximum
tolerated dose was determined using guidelines
from the New Drug Approval Methods 5. One
dose of Jiang Tang Fang Long Jiao Nang was
administered in 20 healthy Kunming mice via an
orogastric feeding tube. The dose was prepared to
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* P＜0.05, ** P＜0.01, compared to pretreatment levels. # P＜0.05, ##P＜0.01, compared to the control.
Group
Treatmetnt
Control
Before
After
Symptom-
free(%)
Before
After
Symptom-
free (%)
Total
164
132
Polydipsia
142
14
128(90.1)*#
110
44
66 (60)*
Hunger
156
8
148(94.8)**##
120
54
66 (55)*
Urine
volume (L)
150
4
146(97.3)**#
132
32
100(75.5)**
Pain
140
10
130(92.8)**##
94
34
60(63.8)
Weakness &
Weight loss
122
6
116 (95)**#
100
52
48 (48)*
Dark Tongue
Color
98
32
66 (67.3)*
68
40
28 (41.1)
Table 3 Comparison of symptom improvement (No. of cases)
Group
Treatment
Control
Before
After
Before
After
No. of Cases
164
132
Adhesion Rate（%）
53.2±7.1
51.0±5.5*
53.7±6.6
54.4±5.2
Aggregation Rate（%）
65.8 ± 9.1
58.2 ± 8.0**##
66.1 ± 8.5
54.2 ± 7.4
SOD（ma/L）
98.17 ± 1.21
109.5 ± 0.43**##
98.56 ± 10.30
101.76 ± 18.50
LPO(mm01/L)
6.84 ± 0.92
4.85 ± 0.98**#
6.74 ± 0.89
5.96 ± 0.95*
Table 4 Comparisons of platelet function, SOD and LPO（mean ±SD）
the animal’s maximum tolerable volume（0.8 mt/
20g） and concentration（0.75/mt）. Animal were
observed for their activities, feeding and excretion
over the next 7 days. Animals were sacrificed on
Day 7 for examination of its internal organs. There
was no animal death during the 7 day observation
period. There was a 1.81 ± 1.33 g weight gain.
Animals showed healthy appearance, with normal
response to stimulation and normal spontaneous
activities including feeding and excretion. Upon
autopsy, no abnormalities were noticed of vital
organs including heart, liver, spleen, lungs, kidney,
etc. The maximum tolerated dose was determined
to be greater than 30 g/kg, about 245 folds of the
dose used in patients.
2.2Long-term Toxicity Test: Healthy rats（80-
120g, n = 80, equal number of males and females）
were randomly divided into four groups（20 in
each group） after a 7 day housebreak period.
Animals in three groups received Jiang Tang Fang
Long Jiao Nang suspension at a daily morning
dose of 30 g/kg, 10 g/kg and 3.3 g/kg respectively,
while those in the remaining group served as
controls group and received equal volume of
distilled water. Half of the animals in each group
were sacrificed at 3 months for serum biochemical
panel tests and histological examination of tissues
from the heart, liver, kidney, spleen, adrenal gland,
pancreas, small intestine and brain. Except for
decreased blood urea nitrogen levels in animals
receiving daily 30 g/kg Jiang Tang Fang Long Jiao
Nang（P < 0.05）, all biochemical indices, white
blood cell count/differentiation and body weight
showed little or no difference（P<0.05）before and
after treatment and among all groups. Histological
examination showed no signs of inflammation,
atrophy, necrosis or any other pathological
changes in sampled organs in all four groups.
2.3 Hypoglycemic and lipid-lowering effects:
Following previously reported protocols6, 5%
tetraoxypyrimidine（prepared with cold saline）
was injected subcutaneously at 0.34 mt/100 g to
male and female Wistar rats after the 1 week
housebreak period. At 2 weeks, tail vein blood
samples were collected while animals were
anesthetized with intraperitoneal injection of 2%
pentobarbital（0.2 mt/100 g）. Serum glucose levels
were determined using glucose oxidase method,
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Group
High Dose
Low Dose
Yu Quan Wan
Control
Number
10
12
11
10
before
after
before
after
before
after
before
after
GLU（mm01/L）
28.89±0.86
21.86 ±1.45**##
28.60±0.95
23.28±1.25*##
28.85±1.02
22.62±1.18*#
28.76±1.05
28.60±1.69
TG (mm01/L)
0.34±0.06
0.09±0.04**##
0.29±0.02
0.15±0.07**##
0.35±0.01
0.34±0.08**#
0.32±0.07
0.32±0.04
Table 5 Glucose(GLU) and triglyceride changes (TG)（mean ± SD）
*P＜0.05, **P＜0.01, compared to pretreatment levels. #P＜0.05, ##P＜0.01, compared to the control.
and triglyceride levels using GPO enzymatic assay.
Eighty animals whose glucose levels were at 22.2
mml/L or higher were selected to be treated with
alloxan for induction of diabetes. Diabetic animals
were then randomly divided into 4 groups to
receive high dose Jiang Tang Fang Long Jiao Nang
（25 g/kg）, low dose Jiang Tang Fang Long Jiao
Nang （10 g/kg）, Yu Quan Wan （an herbal
preparation containing kudzu vine root,
tricosanthes kirilowii, rehmannia glutinosa,
ophionogon japonicus and Fructus Schisandrae
Chinensis）, or to serve as controls, respectively.
Jiang Tang Fang Long Jiao Nang and Yu Quan Wan
were mixed with the forage and orally fed to the
animals. Animals in the control group were fed
with normal forage with no medications. All
animals had unrestricted access to drinking water.
Tail vein blood was sampled under general
anesthesia at 2 weeks for testing of glucose and
triglyceride levels. Animals in the three treatment
groups showed lower glucose levels compared to
before treatment（P < 0.05） and to those in the
control group（P < 0.05）. However, decrease of
triglyceride levels was seen only in Jiang Tang
Fang Long Jiao Nang -treated animals（P<0.05）,
but not in Yu Quan Wan-treated or non-treated
animals.
Discussion
Development of the Jiang Tang Fang Long Jiao
Nang formula is based on the finding in a previous
study that diabetic patients with hearing loss
demonstrated signs of Kidney Deficiency and
Blood Stasis, which lead to clinical symptoms. In
the formula, ligusticum wallichii opens up the 12
channels and, together with salvia root, promotes
Blood movement through reducing Blood Stasis.
Kudzu vine root sends up the lucid Yang and thus
promotes upward movement of the drugs.
Rehmannia glutinosa can enrich the Blood,
nourish the Kidney and replenish the Essence.
Anhui yam strengthens the Spleen and Stomach
and facilitates food movement and digestion. Poris
cocos is used to excrete dampness in the Spleen.
Alisma plantago-aquitica var. orientale helps clear
up the Kidney. Peony root bark reduces Heat in
the Liver. Shanshuyu nourishes the Liver and
Kidney. Magnet serves to support Yin in the
Kidney, reduces Blood Stasis and, according to
Ben Cao Yan Yi（Augmented Materia Medica）,
“can be used in all patients with Kidney
Deficiency, deafness and impaired vision”.
Our clinical data suggest that the Jiang Tang
Fang Long Jiao Nang can improve SOD levels,
lower blood glucose, blood lipids and fibrinogen,
improve platelet function indices, and improve
hearing in NIDDM patients with hearing loss.
Our animal study data indicate that the Jiang
Tang Fang Long Jiao Nang is safe in both short
and long term uses. The data also show that the
Jiang Tang Fang Long Jiao Nang reduces blood
glucose and serum triglyceride contents in
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tetraoxypyrimidine-induced diabetic models. The
Jiang Tang Fang Long Jiao Nang is therefore an
effective and safe treatment option for NIDDM
patients with hearing loss.
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